Significant Vendor (Details Textual) (USD $)
|
3 Months Ended |
9 Months Ended |
12 Months Ended |
|
|
Mar. 31, 2015
|
Mar. 31, 2014
|
Mar. 31, 2015
|
Mar. 31, 2014
|
Jun. 30, 2013
|
Jun. 30, 2014
|
May 31, 2015
|
Significant Vendor [Line Items] |
|
|
|
|
|
|
|
Accounts Payable, Current |
$ 815,000us-gaap_AccountsPayableCurrent
|
|
$ 815,000us-gaap_AccountsPayableCurrent
|
|
|
$ 297,000us-gaap_AccountsPayableCurrent
|
|
Accrued Liabilities, Current |
405,000us-gaap_AccruedLiabilitiesCurrent
|
|
405,000us-gaap_AccruedLiabilitiesCurrent
|
|
|
98,000us-gaap_AccruedLiabilitiesCurrent
|
|
Research and Development Expense |
815,000us-gaap_ResearchAndDevelopmentExpense
|
343,000us-gaap_ResearchAndDevelopmentExpense
|
2,731,000us-gaap_ResearchAndDevelopmentExpense
|
1,480,000us-gaap_ResearchAndDevelopmentExpense
|
|
|
|
General and Administrative Expense Settlement |
1,222,000us-gaap_GeneralAndAdministrativeExpense
|
951,000us-gaap_GeneralAndAdministrativeExpense
|
3,574,000us-gaap_GeneralAndAdministrativeExpense
|
2,950,000us-gaap_GeneralAndAdministrativeExpense
|
|
|
|
Revenue, Net, Total |
349,000us-gaap_SalesRevenueNet
|
0us-gaap_SalesRevenueNet
|
1,535,000us-gaap_SalesRevenueNet
|
0us-gaap_SalesRevenueNet
|
|
|
|
Settlement Agreement [Member] |
|
|
|
|
|
|
|
Significant Vendor [Line Items] |
|
|
|
|
|
|
|
Accounts Payable, Current |
|
|
|
|
1,200,000us-gaap_AccountsPayableCurrent / us-gaap_FinancialInstrumentAxis = ibio_SettlementAgreementMember
|
|
|
Accrued Liabilities, Current |
|
|
|
|
1,700,000us-gaap_AccruedLiabilitiesCurrent / us-gaap_FinancialInstrumentAxis = ibio_SettlementAgreementMember
|
|
|
Research and Development Expense |
|
|
1,040,000us-gaap_ResearchAndDevelopmentExpense / us-gaap_FinancialInstrumentAxis = ibio_SettlementAgreementMember
|
|
|
|
|
Prepaid Expense |
|
|
|
|
1,000,000us-gaap_PrepaidExpenseCurrentAndNoncurrent / us-gaap_FinancialInstrumentAxis = ibio_SettlementAgreementMember
|
|
|
General and Administrative Expense Settlement |
|
|
700,000us-gaap_GeneralAndAdministrativeExpense / us-gaap_FinancialInstrumentAxis = ibio_SettlementAgreementMember
|
|
|
|
|
Earnings From Reversal of Expenses |
|
|
1,900,000ibio_EarningsFromReversalOfExpenses / us-gaap_FinancialInstrumentAxis = ibio_SettlementAgreementMember
|
|
|
|
|
Interest Expense, Total |
|
|
122,000us-gaap_InterestExpense / us-gaap_FinancialInstrumentAxis = ibio_SettlementAgreementMember
|
|
|
|
|
Amended Agreement [Member] |
|
|
|
|
|
|
|
Significant Vendor [Line Items] |
|
|
|
|
|
|
|
Research and Development Expense |
|
|
|
|
1,007,000us-gaap_ResearchAndDevelopmentExpense / us-gaap_FinancialInstrumentAxis = ibio_AmendedAgreementMember
|
|
|
General and Administrative Expense Settlement |
|
|
|
|
1,007,000us-gaap_GeneralAndAdministrativeExpense / us-gaap_FinancialInstrumentAxis = ibio_AmendedAgreementMember
|
|
|
Revenue, Net, Total |
349,000us-gaap_SalesRevenueNet / us-gaap_FinancialInstrumentAxis = ibio_AmendedAgreementMember
|
|
1,535,000us-gaap_SalesRevenueNet / us-gaap_FinancialInstrumentAxis = ibio_AmendedAgreementMember
|
|
|
|
|
Fraunhofer [Member] |
|
|
|
|
|
|
|
Significant Vendor [Line Items] |
|
|
|
|
|
|
|
Accounts Payable, Current |
341,000us-gaap_AccountsPayableCurrent / us-gaap_CounterpartyNameAxis = ibio_FraunhoferMember
|
|
341,000us-gaap_AccountsPayableCurrent / us-gaap_CounterpartyNameAxis = ibio_FraunhoferMember
|
|
2,900,000us-gaap_AccountsPayableCurrent / us-gaap_CounterpartyNameAxis = ibio_FraunhoferMember
|
205,000us-gaap_AccountsPayableCurrent / us-gaap_CounterpartyNameAxis = ibio_FraunhoferMember
|
0us-gaap_AccountsPayableCurrent / us-gaap_CounterpartyNameAxis = ibio_FraunhoferMember
|
Accrued Liabilities, Current |
325,000us-gaap_AccruedLiabilitiesCurrent / us-gaap_CounterpartyNameAxis = ibio_FraunhoferMember
|
|
325,000us-gaap_AccruedLiabilitiesCurrent / us-gaap_CounterpartyNameAxis = ibio_FraunhoferMember
|
|
|
|
|
Research and Development Expense |
|
|
1,535,000us-gaap_ResearchAndDevelopmentExpense / us-gaap_CounterpartyNameAxis = ibio_FraunhoferMember
|
375,000us-gaap_ResearchAndDevelopmentExpense / us-gaap_CounterpartyNameAxis = ibio_FraunhoferMember
|
|
|
|
Royalty Expense |
|
|
200,000us-gaap_RoyaltyExpense / us-gaap_CounterpartyNameAxis = ibio_FraunhoferMember
|
|
|
|
|
Royalty Guarantees, Commitments, Amount |
4,000,000us-gaap_RoyaltyGuaranteesCommitmentsAmount / us-gaap_CounterpartyNameAxis = ibio_FraunhoferMember
|
|
4,000,000us-gaap_RoyaltyGuaranteesCommitmentsAmount / us-gaap_CounterpartyNameAxis = ibio_FraunhoferMember
|
|
|
|
|
Prepaid Expense |
|
|
|
|
1,000,000us-gaap_PrepaidExpenseCurrentAndNoncurrent / us-gaap_CounterpartyNameAxis = ibio_FraunhoferMember
|
|
|
Revenue, Net, Total |
|
|
$ 348,000us-gaap_SalesRevenueNet / us-gaap_CounterpartyNameAxis = ibio_FraunhoferMember
|
$ 77,000us-gaap_SalesRevenueNet / us-gaap_CounterpartyNameAxis = ibio_FraunhoferMember
|
|
|
|